Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination injection used as a control treatment in a clinical trial conducted by Loma Linda University for subacromial impingement syndrome and partial thickness rotator cuff tears. It consists of the corticosteroid triamcinolone acetonide (Kenalog) and the local anesthetics lidocaine and ropivacaine. Triamcinolone acetonide is a synthetic glucocorticoid that exerts anti-inflammatory and immunosuppressive effects by binding to the glucocorticoid receptor, thereby inhibiting the production of inflammatory mediators. Lidocaine and ropivacaine are aminoamide-type local anesthetics that block voltage-gated sodium channels, providing immediate pain relief. This combination is administered via subacromial injection to reduce inflammation and pain associated with rotator cuff syndrome.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on triamcinolone acetonide + lidocaine + ropivacaine.